Analysts Set Biogen Inc. (NASDAQ:BIIB) Price Target at $211.96
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned an average recommendation of “Hold” from the thirty research firms that are covering the firm, MarketBeat.com reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among […]
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned an average recommendation of “Hold” from the thirty research firms that are covering the firm, MarketBeat.com reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among […]
